trending Market Intelligence /marketintelligence/en/news-insights/trending/nrD095MnOrnVrIq-O954qw2 content esgSubNav
In This List

Seattle Genetics COO resigns

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Seattle Genetics COO resigns

Eric Dobmeier resigned as COO of Seattle Genetics Inc., effective Jan. 1, 2018.

Dobmeier resigned to assume the CEO position with a private biotech company.